Dauntless Investment Group LLC Takes $186,000 Position in enVVeno Medical Corporation (NASDAQ:NVNO)

Key Points

• Dauntless Investment Group LLC has acquired 70,848 shares of enVVeno Medical Corporation, worth approximately $186,000, representing about 0.40% of the company's stock.
• Other institutional investors, including Jane Street Group and Virtu Financial, also purchased new positions in enVVeno Medical during the 4th quarter, contributing to a total institutional ownership of 34.71%.
• enVVeno Medical's stock opened at $5.17 and has shown a one-year trading range between a low of $2.03 and a high of $5.91, with reported earnings of ($0.22) EPS for the quarter.

Dauntless Investment Group LLC acquired a new position in shares of enVVeno Medical Corporation (NASDAQ:NVNO - Free Report) during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor acquired 70,848 shares of the company's stock, valued at approximately $186,000. Dauntless Investment Group LLC owned approximately 0.40% of enVVeno Medical as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors have also added to or reduced their stakes in the business. Jane Street Group LLC bought a new position in enVVeno Medical in the 4th quarter worth about $56,000. National Bank of Canada FI bought a new position in enVVeno Medical in the 4th quarter worth about $60,000. Northern Trust Corp increased its stake in enVVeno Medical by 68.3% in the 4th quarter. Northern Trust Corp now owns 56,725 shares of the company's stock worth $171,000 after acquiring an additional 23,029 shares during the last quarter. Virtu Financial LLC bought a new position in enVVeno Medical in the 4th quarter worth about $86,000. Finally, Geode Capital Management LLC increased its stake in enVVeno Medical by 20.6% in the 4th quarter. Geode Capital Management LLC now owns 181,737 shares of the company's stock worth $549,000 after acquiring an additional 31,061 shares during the last quarter. 34.71% of the stock is currently owned by institutional investors.

enVVeno Medical Price Performance

NASDAQ NVNO traded up $0.19 during trading on Friday, reaching $4.80. The company's stock had a trading volume of 94,580 shares, compared to its average volume of 107,165. The stock has a market capitalization of $84.12 million, a PE ratio of -4.06 and a beta of 0.93. The firm has a fifty day moving average of $4.22 and a 200 day moving average of $3.47. enVVeno Medical Corporation has a one year low of $2.03 and a one year high of $5.81.

enVVeno Medical (NASDAQ:NVNO - Get Free Report) last announced its quarterly earnings data on Thursday, July 31st. The company reported ($0.33) EPS for the quarter, missing the consensus estimate of ($0.28) by ($0.05). Research analysts expect that enVVeno Medical Corporation will post -1.32 earnings per share for the current fiscal year.

About enVVeno Medical

enVVeno Medical Corporation Nasdaq: NVNO is an medical device company focused on the development of innovative bioprosthetic (tissue-based) devices to improve the standard of care in the treatment of venous disease. The company's lead product, the VenoValve®️, is a first-in-class, surgical implant being developed for the treatment of severe deep venous Chronic Venous Insufficiency (CVI).